32
Participants
Start Date
May 17, 2010
Primary Completion Date
April 13, 2015
Study Completion Date
April 13, 2015
Carboplatin
Carboplatin will be administered at a concentration-time curve (AUC) of 5-6 (at the discretion of the physician) day 1 every 3 weeks in combination with Paclitaxel and Bevacizumab.
Paclitaxel
Paclitaxel 175 mg/m2 over 3 hours day 1 every 3 weeks in combination with Carboplatin and Bevacizumab.
Bevacizumab
Bevacizumab 15 mg/kg day 1 every 3 weeks in combination with Paclitaxel and Carboplatin.
Columbia University Medical Center, New York
Fox Chase Cancer Center, Philadelphia
University of Virginia, Charlottesville
Collaborators (1)
Genentech, Inc.
INDUSTRY
Jason D. Wright
OTHER